The antiviral drug tecovirimat (Tpoxx) didn't accelerate lesion clearance in adults and children with clade 1 mpox ...

The global outbreak of mpox in 2022–23 affected more than 100 countries and grabbed the attention of the scientific community ...

A case of Clade Ib mpox virus has been confirmed in the North East of England, but no links have been found to other known ...

Insufficient research on mpox hinders effective control strategies, emphasizing the need to understand its transmission and ...

The risk to the UK population remains low. Clade Ia and Ib mpox are no longer classified as a high consequence infectious disease (HCID). UKHSA has robust mechanisms in place to investigate suspected ...

All previous mpox cases in the UK were found in someone who travelled to an affected country or knew someone who had ...

The first phase of this training has been completed. Following the completion of the second phase, the vaccine will be ...

A number of Clade 1b mpox cases have been identified in the UK since October 2024. The latest confirmed case comes after the ...

Britain's health security agency said on Monday another case of the mpox variant clade lb had been detected in England in a ...

As the UK navigates this unexpected case of mpox, health authorities continue to stress the importance of awareness and ...

The risk to the general population is very low. However, travellers to affected countries who mix with affected communities are at risk of contracting mpox and transmitting it to close contacts on ...

The government agency was keen to stress that the risk to the UK population remains low. Common symptoms of mpox include a skin rash or pus-filled lesions which can last 2 to 4 weeks. It can also ...